Etesevimab
Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody[1].
Product Specifications
CAS Number
[2423948-94-9]
Product Name Alternative
CB 6; JS016
UNSPSC
12352203
Target
Angiotensin-converting Enzyme (ACE) ; SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/etesevimab.html
Purity
98.76
Solubility
H2O
Smiles
[Etesevimab]
Molecular Weight
(145.18 kDa)
References & Citations
[1]Wu X, et al. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study. Antimicrob Agents Chemother. 2021 Jul 16;65 (8) :e0035021.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
